迪卡斯 DCTH 深 沪
等待开盘 08-13 09:30:00 美东时间
10.88
+0.370
+3.52%
华盛通- 最 高10.95
- 今 开10.57
- 成交量 77.69万股
- 最 低 10.4255
- 昨 收 10.51
- 总市值 3.79亿
- 52周最高 18.23
- 市盈率 静 --
- 换手率 2.23%
- 52周最低 8.08
- 委 比 -61.01%
- 总股本 3482.62万
- 历史最高 9368800000.00
- 量 比 0.48
- 振 幅 4.99%
- 历史最低 2.25
- 每 手 1
- 风险率 2.33%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Delcath Systems shares are trading higher after the company reported better-than-expected Q2 financial results.
Delcath Systems shares are trading higher after the company reported better-tha...
08-06 20:35
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
美股大行评级 | 买入！Darden Restaurants获多家大行上调目标价；瑞银维持特斯拉"卖出"评级，目标价升至215美元
买入！Darden Restaurants获多家大行上调目标价；瑞银维持特斯拉"卖出"评级，目标价升至215美元>>
06-24 10:07
Stephens & Co. Reiterates Overweight on Delcath Systems, Maintains $25 Price Target
Stephens & Co. analyst Sudan Loganathan reiterates Delcath Systems (NASDAQ:DCTH) with a Overweight and maintains $25 price target.
06-23 23:01
美股大行评级 | 潜在涨幅112.77%！Craig-Hallum上调PLAYSTUDIOS目标价至3美元，评级升至"买入"
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1132955525493317632.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Craig-Hallum：上调PLAYSTUDIOS(MYPS)评级至"买入"，目标价从2美元升至3美元</p> <p>• Leerink Partners：上调Fulcrum Therapeutics(FULC)评级至"
05-24 08:40
快讯 | 迪卡斯公司：H.c. Wainwright 将目标价从24美元上调至29美元
Delcath Systems, Inc. : H.c. Wainwright Raises Target Price to $29 From $24
05-23 18:04
Delcath Systems shares are trading higher after the company issued FY25 guidance and provided business updates.
Delcath Systems shares are trading higher after the company issued FY25 guidanc...
05-22 20:18
Delcath Systems Announces 2025 Financial Guidance
The latest update is out from Delcath Systems ( ($DCTH) ). On May 22, 2025, Del...
05-22 19:49
Delcath Systems Sees 2025 CHEMOSAT And HEPZATO KIT Revenue Climbing To $94M–$98M In 2025, Up Over 150% YoY, Sees 83%–85% Gross Margins
2025 Full Year Total Revenue Guidance of $94 to $98 millionDelcath Announces Plan to Enter into National Medicaid Drug Rebate Agreement
05-22 19:08
